腫瘤壞死因子相關凋亡誘導配體(TRAIL)多克隆抗體(生物素標記)
Biotin-Linked Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
CD253; TNFSF10; APO2L; Apo2-L; TL2; TRAIL; Tumor Necrosis Factor Ligand Superfamily Member 10; Apo-2 Ligand
- 編號ULAA139Mu71
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源抗體標記
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物生物素
- 原抗體 -
- 緩沖液成份磷酸鹽緩沖液（pH7.4, 含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.）
- 性狀液體
- 濃度500μg/mL
- 且適物種Homo sapiens (Human，人)
- 應用WB
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 320 ¥ 748 ¥ 1068 ¥ 2670 ¥ 10680
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
Western Blot; Sample: A549 cell lysate
Primary Ab: 0.2μg/ml Biotin-Linked Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
Second Ab: 0.2μg/ml HRP-Labeled Streptavidin (Catalog: IS089)
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對TRAIL的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別TRAIL。
用法
免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學：5-20μg/mL;1:25-100
免疫細胞化學：5-20μg/mL;1:25-100
最佳稀釋倍數最終由用戶決定。
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| URPA139Mu01 | 腫瘤壞死因子相關凋亡誘導配體(TRAIL)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA139Mu02 | 腫瘤壞死因子相關凋亡誘導配體(TRAIL)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAA139Mu01 | 腫瘤壞死因子相關凋亡誘導配體(TRAIL)多克隆抗體 | WB; ICC/IF |
| UPAA139Mu02 | 腫瘤壞死因子相關凋亡誘導配體(TRAIL)多克隆抗體 | WB; IHC; ICC; IP. |
| ULAA139Mu71 | 腫瘤壞死因子相關凋亡誘導配體(TRAIL)多克隆抗體(生物素標記) | WB |
| USEA139Mu | 腫瘤壞死因子相關凋亡誘導配體(TRAIL)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| UWEA139Mu | 腫瘤壞死因子相關凋亡誘導配體(TRAIL)檢測試劑盒(酶聯免疫吸附試驗法,寬范圍) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMA139Mu | 腫瘤壞死因子相關凋亡誘導配體(TRAIL)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UKSA139Mu01 | 腫瘤壞死因子相關凋亡誘導配體(TRAIL)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| PLOS ONE | Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model [Pubmed:25506835] |
| PLOS ONE | Soluble TRAIL Concentration in Serum Is Elevated in People with Hypercholesterolemia [PubMed: 26633016] |
| Scientific Reports | Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice [pubmed:28507343] |
| Journal of Molecular Medicine | TRAIL and TRAIL Receptors as Prognostic Markers in Breast Cancer Patients [Pubmed: 31183506] |
| life sciences | Nifuroxazide attenuates experimentally-induced hepatic encephalopathy and the associated hyperammonemia and cJNk/caspase-8/TRAIL activation in rats [Pubmed: 32259601] |
| Int Immunopharmacol | Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling [Pubmed: 33199237] |
| ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY | Chemo-preventive effect of crocin against experimentally-induced hepatocarcinogenesis via regulation of apoptotic and Nrf2 signaling pathways [Pubmed: 32942000] |
| J Biochem Mol Toxicol | Tranilast abrogates cisplatin?\induced testicular and epididymal injuries: An insight into its modulatory impact on apoptosis/proliferation [34047436] |
留言咨詢
